SIGA Technologies, Inc. (SIGA) DCF Valuation

SIGA Technologies, Inc. (SIGA) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

SIGA Technologies, Inc. (SIGA) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Explore SIGA Technologies, Inc. (SIGA) financial outlook with our user-friendly DCF Calculator! Enter your projections for growth, margins, and expenses to calculate SIGA's intrinsic value and inform your investment decisions.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 26.7 125.0 133.7 110.8 139.9 180.5 233.0 300.6 387.9 500.6
Revenue Growth, % 0 367.28 6.97 -17.13 26.31 29.04 29.04 29.04 29.04 29.04
EBITDA 1.0 85.0 89.6 43.2 84.2 86.0 110.9 143.2 184.7 238.4
EBITDA, % 3.84 68.05 67.04 39.01 60.15 47.62 47.62 47.62 47.62 47.62
Depreciation .5 .5 .5 .5 .5 1.3 1.7 2.2 2.8 3.6
Depreciation, % 1.97 0.42399 0.39079 0.46729 0.38472 0.72749 0.72749 0.72749 0.72749 0.72749
EBIT .5 84.5 89.1 42.7 83.6 84.7 109.2 141.0 181.9 234.7
EBIT, % 1.87 67.62 66.65 38.55 59.76 46.89 46.89 46.89 46.89 46.89
Total Cash 65.2 117.9 103.1 98.8 150.1 166.3 214.7 277.0 357.4 461.2
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 4.2 3.3 83.7 45.4 21.1
Account Receivables, % 15.59 2.67 62.58 40.99 15.1
Inventories 9.7 20.3 19.5 39.3 64.2 53.5 69.1 89.1 115.0 148.4
Inventories, % 36.1 16.22 14.6 35.45 45.9 29.65 29.65 29.65 29.65 29.65
Accounts Payable 3.1 1.3 2.0 3.4 1.5 6.5 8.4 10.8 14.0 18.1
Accounts Payable, % 11.42 1.02 1.52 3.03 1.04 3.61 3.61 3.61 3.61 3.61
Capital Expenditure .0 .0 -.1 .0 .0 -.1 -.1 -.1 -.1 -.2
Capital Expenditure, % -0.10879 -0.01240484 -0.03786925 0 -0.01549916 -0.03491361 -0.03491361 -0.03491361 -0.03491361 -0.03491361
Tax Rate, % 22.45 22.45 22.45 22.45 22.45 22.45 22.45 22.45 22.45 22.45
EBITAT .4 64.8 69.3 32.8 64.8 64.3 83.0 107.1 138.2 178.3
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -9.9 53.7 -9.1 53.1 62.8 53.0 56.6 73.0 94.3 121.6
WACC, % 8.62 8.63 8.63 8.63 8.63 8.62 8.62 8.62 8.62 8.62
PV UFCF
SUM PV UFCF 301.9
Long Term Growth Rate, % 3.50
Free cash flow (T + 1) 126
Terminal Value 2,456
Present Terminal Value 1,624
Enterprise Value 1,926
Net Debt -150
Equity Value 2,076
Diluted Shares Outstanding, MM 72
Equity Value Per Share 28.96

What You Will Get

  • Pre-Filled Financial Model: SIGA Technologies' actual data enables precise DCF valuation.
  • Full Forecast Control: Adjust revenue growth, margins, WACC, and other key drivers tailored for SIGA (SIGA).
  • Instant Calculations: Automatic updates ensure you see results as you make changes to SIGA's financials.
  • Investor-Ready Template: A refined Excel file designed for professional-grade valuation of SIGA (SIGA).
  • Customizable and Reusable: Tailored for flexibility, allowing repeated use for detailed forecasts of SIGA (SIGA).

Key Features

  • Comprehensive SIGA Data: Pre-loaded with SIGA Technologies’ historical performance metrics and future projections.
  • Tailorable Inputs: Modify growth rates, profit margins, discount rates, tax implications, and capital investments.
  • Interactive Valuation Model: Real-time updates to Net Present Value (NPV) and intrinsic valuation based on your adjustments.
  • Scenario Analysis: Develop various forecasting scenarios to evaluate different valuation possibilities.
  • Intuitive Interface: Clean, organized, and crafted for both industry professionals and novices.

How It Works

  • Step 1: Download the prebuilt Excel template featuring SIGA Technologies, Inc. (SIGA) data.
  • Step 2: Review the pre-filled sheets to familiarize yourself with the essential metrics.
  • Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly see the recalculated results, including SIGA's intrinsic value.
  • Step 5: Utilize the outputs to make informed investment choices or create comprehensive reports.

Why Choose SIGA Technologies, Inc. (SIGA)?

  • Innovative Solutions: Access cutting-edge technologies that address critical health challenges.
  • Proven Track Record: Established history of delivering effective therapeutics for infectious diseases.
  • Expert Team: Collaborate with industry leaders and scientists dedicated to advancing public health.
  • Commitment to Quality: Rigorous standards ensure the highest level of product safety and efficacy.
  • Investor Confidence: Backed by a solid financial foundation and a clear growth strategy.

Who Should Use This Product?

  • Professional Investors: Develop comprehensive and accurate valuation models for portfolio assessment of SIGA Technologies, Inc. (SIGA).
  • Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within their organizations regarding SIGA.
  • Consultants and Advisors: Deliver precise valuation insights to clients interested in SIGA Technologies, Inc. (SIGA) investments.
  • Students and Educators: Utilize real-world data to enhance financial modeling skills and education focused on SIGA.
  • Biotech Enthusiasts: Gain insights into how biotech firms like SIGA Technologies, Inc. (SIGA) are valued in the marketplace.

What the Template Contains

  • Preloaded SIGA Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.

No products were found matching.